Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Hormone-Dependent Prostate Cancer With PSA Progression
NCT00726596Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Aug 2008
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in prostate cancer (PCa), sponsored by Rutgers University. Started Aug 2008; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00726596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00726596.